Rami Ben‐Joseph

2.7k total citations
71 papers, 2.1k citations indexed

About

Rami Ben‐Joseph is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rami Ben‐Joseph has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 15 papers in Geriatrics and Gerontology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rami Ben‐Joseph's work include Opioid Use Disorder Treatment (17 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Rami Ben‐Joseph is often cited by papers focused on Opioid Use Disorder Treatment (17 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Rami Ben‐Joseph collaborates with scholars based in United States, Canada and United Kingdom. Rami Ben‐Joseph's co-authors include Josephine Mauskopf, K Downs, Mohan Bala, Mac Cochrane, Vahram Ghushchyan, Patrick W. Sullivan, L. Clark Paramore, Dhvani Shah, M Blieden and Howard G. Birnbaum and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rami Ben‐Joseph

71 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rami Ben‐Joseph United States 25 712 500 490 294 218 71 2.1k
Theresa Anderson United States 14 220 0.3× 333 0.7× 362 0.7× 320 1.1× 518 2.4× 23 3.5k
Hong Yup Ahn South Korea 28 511 0.7× 130 0.3× 505 1.0× 499 1.7× 228 1.0× 134 2.4k
Michael F. Mayo‐Smith United States 17 289 0.4× 270 0.5× 652 1.3× 392 1.3× 72 0.3× 33 2.6k
Phil Alderson United Kingdom 25 271 0.4× 392 0.8× 391 0.8× 374 1.3× 135 0.6× 42 2.8k
Diana M Sobieraj United States 26 415 0.6× 366 0.7× 203 0.4× 134 0.5× 189 0.9× 93 2.3k
K. Lenz Austria 31 432 0.6× 486 1.0× 197 0.4× 1.1k 3.7× 107 0.5× 92 3.2k
Hadas D. Fischer Canada 30 180 0.3× 323 0.6× 206 0.4× 464 1.6× 125 0.6× 83 2.9k
Marco L.A. Sivilotti Canada 36 151 0.2× 324 0.6× 502 1.0× 446 1.5× 321 1.5× 135 3.8k
Priscilla Chew United States 21 371 0.5× 212 0.4× 294 0.6× 157 0.5× 114 0.5× 44 2.1k
Vincent Wietlisbach Switzerland 26 417 0.6× 816 1.6× 489 1.0× 375 1.3× 62 0.3× 55 3.0k

Countries citing papers authored by Rami Ben‐Joseph

Since Specialization
Citations

This map shows the geographic impact of Rami Ben‐Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rami Ben‐Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rami Ben‐Joseph more than expected).

Fields of papers citing papers by Rami Ben‐Joseph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rami Ben‐Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rami Ben‐Joseph. The network helps show where Rami Ben‐Joseph may publish in the future.

Co-authorship network of co-authors of Rami Ben‐Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Rami Ben‐Joseph. A scholar is included among the top collaborators of Rami Ben‐Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rami Ben‐Joseph. Rami Ben‐Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ben‐Joseph, Rami, Virend K. Somers, Jed Black, et al.. (2024). Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study. Mayo Clinic Proceedings. 99(11). 1710–1721. 5 indexed citations
2.
Ben‐Joseph, Rami, et al.. (2023). Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study. SLEEP. 46(10). 35 indexed citations
3.
Bell, Jill A., Marco DiBonaventura, Edward A. Witt, Rami Ben‐Joseph, & Bryce B. Reeve. (2016). Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain. Medical Care. 55(2). 111–116. 8 indexed citations
4.
Shei, Amie, et al.. (2015). Sources of prescription opioids among diagnosed opioid abusers. Current Medical Research and Opinion. 31(4). 779–784. 65 indexed citations
5.
Shei, Amie, et al.. (2015). Characteristics of High-Cost Patients Diagnosed with Opioid Abuse. Journal of Managed Care & Specialty Pharmacy. 21(10). 902–912. 21 indexed citations
6.
Kirson, Noam Y., Amie Shei, Howard G. Birnbaum, Rami Ben‐Joseph, & Edward Michna. (2014). Medical resource use and costs among pain patients with potential opioid-tolerability issues. Journal of Opioid Management. 10(5). 305–310. 1 indexed citations
7.
Michna, Edward, Noam Y. Kirson, Amie Shei, Howard G. Birnbaum, & Rami Ben‐Joseph. (2014). Use of prescription opioids with abuse-deterrent technology to address opioid abuse. Current Medical Research and Opinion. 30(8). 1589–1598. 14 indexed citations
8.
DiBonaventura, Marco, Margaret Moline, Dhvani Shah, & Rami Ben‐Joseph. (2014). Impact of middle-of-the-night awakenings on health status, activity impairment, and costs. Nature and Science of Sleep. 6. 101–101. 6 indexed citations
9.
Pergolizzi, Joseph V., et al.. (2014). US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system. Current Medical Research and Opinion. 30(8). 1579–1587. 6 indexed citations
10.
Kirson, Noam Y., Amie Shei, Alan G. White, et al.. (2014). Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States. Pain Medicine. 15(9). 1450–1454. 12 indexed citations
11.
Rice, J. Bradford, Noam Y. Kirson, Amie Shei, et al.. (2014). Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data. Applied Health Economics and Health Policy. 12(4). 435–446. 50 indexed citations
12.
Ben‐Joseph, Rami, et al.. (2014). Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans. Journal of Medical Economics. 17(10). 708–718. 4 indexed citations
13.
Summers, Kent H., et al.. (2011). Economic impact of potential drug–drug interactions in opioid analgesics. Journal of Medical Economics. 14(4). 390–396. 20 indexed citations
14.
Rubino, Mark, et al.. (2011). A Comparison of Daily Average Consumption (DACON) of Oxycodone and Oxymorphone Long-Acting Oral Tablets. Journal of Managed Care Pharmacy. 17(5). 367–376. 8 indexed citations
15.
Boudreau, Denise M., Daniel C. Malone, Marsha A. Raebel, et al.. (2009). Health Care Utilization and Costs by Metabolic Syndrome Risk Factors. Metabolic Syndrome and Related Disorders. 7(4). 305–314. 166 indexed citations
16.
Brixner, Diana, Sameer R. Ghate, Carrie McAdam‐Marx, Rami Ben‐Joseph, & Qayyim Said. (2008). Association Between Cardiometabolic Risk Factors and Body Mass Index Based on Diagnosis and Treatment Codes in an Electronic Medical Record Database. Journal of Managed Care Pharmacy. 14(8). 756–767. 8 indexed citations
17.
Bakhai, Ameet, Marcus Flather, J Collinson, et al.. (2003). National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. International Journal of Cardiology. 91(2-3). 163–172. 7 indexed citations
18.
Valovirta, E., Vasilisa Sazonov Kocevar, Minna Kaila, et al.. (2002). Inpatient resource utilisation in younger (2–5 yrs) and older (6–14 yrs) asthmatic children in Finland. European Respiratory Journal. 20(2). 397–402. 15 indexed citations
19.
Bousquet, Jean, Rami Ben‐Joseph, Mark L. Messonnier, E. Alemao, & A. Lawrence Gould. (2002). A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clinical Therapeutics. 24(1). 1–20. 47 indexed citations
20.
Price, David, Rami Ben‐Joseph, & Q. Zhang. (2001). Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.. Respiratory Medicine. 95(1). 83–89. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026